(Q40695013)

22 September 2017

1 reference

title

Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis (English)

1 reference

22 September 2017

0 references

1 reference

J Beyer

1

1 reference

22 September 2017

S Schwartz

2

1 reference

22 September 2017

G Barzen

3

1 reference

22 September 2017

G Risse

4

1 reference

22 September 2017

K Dullenkopf

5

1 reference

22 September 2017

C Weyer

6

1 reference

22 September 2017

W Siegert

7

1 reference

22 September 2017

publication date

1 March 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

22

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

143-148

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01739026

22 September 2017

exact match

0 references

cites work

Overview of host defenses in fungal infections

1 reference

https://api.crossref.org/works/10.1007%2FBF01739026

Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01739026

Pharmacokinetics of aerosol amphotericin B in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01739026

Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01739026

Regional deposition of aerosolized pentamidine. Effects of body position and breathing pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01739026

Quantitation of amphotericin B with use of high-pressure liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01739026

Primary cutaneous aspergillosis associated with Hickman intravenous catheters

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia

1 reference

12 December 2020

Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients.

1 reference

12 December 2020

A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia

1 reference

12 December 2020

Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study

1 reference

12 December 2020

Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation

1 reference

12 December 2020

Candida and Aspergillus Infections in Immunocompromised Patients: An Overview

1 reference

12 December 2020

Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients

1 reference

12 December 2020

Model of recurrent pulmonary aspergillosis in rats

1 reference

12 December 2020

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

1 reference

12 December 2020

The use of amphotericin B in nosocomial fungal infection.

1 reference

12 December 2020

Fungal infections in cancer patients: an international autopsy survey.

1 reference

12 December 2020

Fungal infections in bone marrow transplant patients

1 reference

12 December 2020

Invasive aspergillus rhinosinusitis in patients with acute leukemia

1 reference

12 December 2020

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

12 December 2020

Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors

1 reference

12 December 2020

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

1 reference

12 December 2020

Interventional antimicrobial strategy in febrile neutropenic patients. Results of a multicenter study in 1,260 patients with hematological malignancies. The Interventional Antimicrobial Strategy Study Group, Paul Ehrlich Society for Chemotherapy

1 reference

12 December 2020

Aspergillus sinusitis in cancer patients

1 reference

12 December 2020

Design characteristics for drug nebulizers

1 reference

12 December 2020

The toxicity of daily inhaled amphotericin B.

1 reference

12 December 2020

Response to empiric amphotericin B during antileukemic therapy-induced granulocytopenia

1 reference

12 December 2020

Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment

1 reference

12 December 2020

Amphotericin B: 30 years of clinical experience

1 reference

12 December 2020

The innocuousness and possible therapeutic use of aerosol amphotericin-B

1 reference

12 December 2020

Combination therapy in a model of pulmonary aspergillosis

1 reference

12 December 2020

Extrinsic risk factors for pneumonia in the patient at high risk of infection

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01739026

1 reference

22 September 2017

1 reference